Stay updated on Guselkumab in Active PsA: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.

Latest updates to the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 has been added and Revision: v3.4.1 has been removed.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.0%

- Check33 days agoChange DetectedAdds UI controls to Show glossary and Hide glossary, affecting user interaction but not core content. Updates metadata and labeling, including capitalization in Last Update Submitted that Met QC Criteria, wording for No FEAR Act Data, and a revision bump to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page shows a revision update from v3.3.3 to v3.3.4, which is a minor metadata change with no impact on the study data, eligibility criteria, outcomes, locations, or scheduling. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded a comprehensive list of study locations, including multiple U.S. states and Ontario, Canada. Updated the revision label and removed the HHS Vulnerability Disclosure link.SummaryDifference1.0%

- Check90 days agoChange DetectedThese changes are minor editorial updates: a PubMed publication note was added and a revision tag was updated to v3.3.2, while the older PubMed note and Revision: v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Guselkumab in Active PsA: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.